LIVE NOW: Golden Buying Window to Ride India's Potentially Decade-Long $10 Trillion Bull Run...
Here is the latest financial fact sheet of NIDAN LABORATORIES. For more details, see the NIDAN LABORATORIES quarterly results and NIDAN LABORATORIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.7 |
No. of shares | m | 13.90 |
1 Week | % | -1.0 |
1 Month | % | 2.5 |
1 Year | % | -29.4 |
52 week H/L | Rs | 57.7/27.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
NIDAN LABORATORIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 91 | 77 | |
Low | Rs | NA | NA | NA | 32 | 31 | |
Sales per share (Unadj.) | Rs | 20.3 | 21.6 | 20.6 | 21.3 | 17.5 | |
Earnings per share (Unadj.) | Rs | 0.2 | 0.7 | 2.3 | 1.9 | 2.5 | |
Diluted earnings per share | Rs | 0.2 | 0.5 | 1.7 | 1.9 | 2.5 | |
Cash flow per share (Unadj.) | Rs | 3.5 | 3.9 | 5.5 | 3.8 | 4.8 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 10.4 | 11.1 | 13.5 | 47.4 | 50.0 | |
Adj. book value per share | Rs | 7.4 | 7.9 | 9.6 | 47.4 | 50.0 | |
Shares outstanding (eoy) | m | 9.90 | 9.90 | 9.90 | 13.90 | 13.90 | |
Price / Sales ratio | x | 0 | 0 | 0 | 2.9 | 3.1 | |
Avg P/E ratio | x | 0 | 0 | 0 | 32.2 | 21.0 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 16.2 | 11.2 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 1.3 | 1.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 858 | 744 | |
Total wages/salary | Rs m | 24 | 28 | 29 | 36 | 49 |
NIDAN LABORATORIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 201 | 214 | 204 | 297 | 243 | |
Other income | Rs m | 4 | 0 | 11 | 4 | 33 | |
Total revenues | Rs m | 204 | 214 | 214 | 301 | 276 | |
Gross profit | Rs m | 78 | 76 | 89 | 94 | 68 | |
Depreciation | Rs m | 32 | 32 | 32 | 26 | 31 | |
Interest | Rs m | 48 | 37 | 35 | 27 | 22 | |
Profit before tax | Rs m | 2 | 7 | 33 | 45 | 48 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 10 | 19 | 13 | |
Profit after tax | Rs m | 2 | 7 | 23 | 27 | 35 | |
Gross profit margin | % | 39.1 | 35.7 | 43.6 | 31.7 | 28.0 | |
Effective tax rate | % | 0 | 0 | 30.3 | 41.1 | 26.4 | |
Net profit margin | % | 1.1 | 3.3 | 11.3 | 9.0 | 14.6 |
NIDAN LABORATORIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 190 | 243 | 229 | 253 | 209 | |
Current liabilities | Rs m | 6 | -2 | 262 | 128 | 95 | |
Net working cap to sales | % | 91.8 | 114.4 | -16.0 | 42.2 | 46.7 | |
Current ratio | x | 33.1 | -142.3 | 0.9 | 2.0 | 2.2 | |
Inventory Days | Days | 10 | 9 | 187 | 473 | 626 | |
Debtors Days | Days | 1,021 | 926 | 973 | 660 | 906 | |
Net fixed assets | Rs m | 238 | 206 | 306 | 627 | 630 | |
Share capital | Rs m | 99 | 99 | 99 | 139 | 139 | |
"Free" reserves | Rs m | 4 | 11 | 34 | 520 | 555 | |
Net worth | Rs m | 103 | 110 | 133 | 659 | 694 | |
Long term debt | Rs m | 322 | 344 | 142 | 94 | 48 | |
Total assets | Rs m | 428 | 450 | 535 | 880 | 839 | |
Interest coverage | x | 1.0 | 1.2 | 2.0 | 2.7 | 3.2 | |
Debt to equity ratio | x | 3.1 | 3.1 | 1.1 | 0.1 | 0.1 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.4 | 0.3 | 0.3 | |
Return on assets | % | 11.6 | 9.9 | 10.8 | 6.1 | 6.9 | |
Return on equity | % | 2.2 | 6.5 | 17.3 | 4.0 | 5.1 | |
Return on capital | % | 11.7 | 9.8 | 24.6 | 9.5 | 9.5 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
NIDAN LABORATORIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 89 | 46 | 43 | 78 | 139 | |
From Investments | Rs m | 10 | -0 | -32 | -357 | -30 | |
From Financial Activity | Rs m | -58 | -16 | -12 | 287 | -106 | |
Net Cashflow | Rs m | 41 | 30 | -1 | 8 | 3 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
COMP SEC: Akshay Joshi | YEAR OF INC: 2000 | NSE CODE: 945013 | FV (Rs): 10 | DIV YIELD (%): - |
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare NIDAN LABORATORIES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.